Lucid Diagnostics Inc.

NasdaqCM:LUCD Stock Report

Market Cap: US$43.3m

Lucid Diagnostics Past Earnings Performance

Past criteria checks 0/6

Lucid Diagnostics's earnings have been declining at an average annual rate of -37.7%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 72.6% per year.

Key information

-37.7%

Earnings growth rate

-18.2%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate72.6%
Return on equity-707.1%
Net Margin-1,248.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

We're A Little Worried About Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate

May 09
We're A Little Worried About Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate

Lucid Diagnostics (NASDAQ:LUCD) Will Have To Spend Its Cash Wisely

Dec 15
Lucid Diagnostics (NASDAQ:LUCD) Will Have To Spend Its Cash Wisely

Lucid Diagnostics launches stage II lucid test center in California, Texas, Florida, and Ohio

Aug 11

We're Keeping An Eye On Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate

Jul 07
We're Keeping An Eye On Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate

Revenue & Expenses Breakdown

How Lucid Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:LUCD Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244-52356
30 Jun 244-54346
31 Mar 243-55337
31 Dec 232-53367
30 Sep 232-57388
30 Jun 231-57399
31 Mar 231-604210
31 Dec 220-564011
30 Sep 221-533712
30 Jun 221-453212
31 Mar 221-372510
31 Dec 211-28189
30 Sep 210-20118
30 Jun 210-1587
31 Mar 210-1046
31 Dec 200-835
30 Sep 200-725
31 Dec 190-413
30 Sep 190-422

Quality Earnings: LUCD is currently unprofitable.

Growing Profit Margin: LUCD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LUCD is unprofitable, and losses have increased over the past 5 years at a rate of 37.7% per year.

Accelerating Growth: Unable to compare LUCD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LUCD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).


Return on Equity

High ROE: LUCD has a negative Return on Equity (-707.13%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 04:44
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lucid Diagnostics Inc. is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Mark MassaroBTIG
Kyle MiksonCanaccord Genuity